126 related articles for article (PubMed ID: 9425746)
1. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
[TBL] [Abstract][Full Text] [Related]
2. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
[TBL] [Abstract][Full Text] [Related]
3. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
[TBL] [Abstract][Full Text] [Related]
5. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
6. Determination of p53 genotypes in oral cancer patients from India.
Tandle AT; Sanghvi V; Saranath D
Br J Cancer; 2001 Mar; 84(6):739-42. PubMed ID: 11259085
[TBL] [Abstract][Full Text] [Related]
7. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers.
Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E
Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of genetic assays to identify oral pre-cancerous fields.
Bremmer JF; Braakhuis BJ; Brink A; Broeckaert MA; Beliën JA; Meijer GA; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
J Oral Pathol Med; 2008 Nov; 37(10):599-606. PubMed ID: 18705641
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
11. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
12. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
14. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
15. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
[TBL] [Abstract][Full Text] [Related]
16. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
[TBL] [Abstract][Full Text] [Related]
17. Lack of molecular markers to predict malignant potential of oral precancer.
Warnakulasuriya S
J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]